Roundup of 2022 NIH Funding Opportunities: Let Duke CTSI Help You Apply!

CTSI News logo image

The following NIH funding opportunities are available in 2022. If interested in any of these opportunities, Duke investigators should contact:

Cinthia E. Sanchez, Ph.D. | CTSA Program Director 
Duke Clinical & Translational Science Institute (CTSI) 
cinthia.sanchez@duke.edu
Pronouns: She, Her, Hers

New Opportunities

Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship

RADx®-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)

  • This FOA RFA-OD-22-005 provides an expedited funding mechanism to support Phase III of the Rapid Acceleration of Diagnostics – Underserved Populations (RADx®-UP) initiative.
  • The goal of this RADx®-UP FOA is to conduct SEBI research to understand and reduce barriers to COVID-19 testing, as well as COVID-19 disparities that arise from barriers to testing among underserved and vulnerable populations, and to focus on and  psychological and communication science interventions to improve uptake of testing and vaccination.
  • The funding for this initiative is provided from the American Rescue Plan Act of 2021, PL 117-2.
  •  Open Date (Earliest Submission Date): April 04, 2022

RADx-UP Community-Engaged Research on Rapid SARS-CoV-2 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)

  • These two-year, community-engaged Rapid Testing Research Projects will examine SARS-CoV-2 infection patterns and interventions to increase access to and uptake of diagnostic methods through the RADx®-UP initiative.
  • Open Date for RFA-OD-22-006 (Earliest Submission Date): April 04, 2022
  •  The funding for these initiative is provided from the American Rescue Plan Act of 2021, PL 117-2.
  • There will be a RADx-UP Phase III Pre Application Webinar to discuss and share the new opportunities with the research community on March 8th from 1 pm – 3 pm. Register https://deloitte.zoom.us/webinar/register/WN_r7OCs8Q5R-yJCDSQnviZEw
  • https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-006.html

Notice of Special Interest (NOSI): Early-life Factors and Cancer Development Later in Life

Funding Opportunity for Osteoporosis Research

Funding opportunity that encourage more intensive analysis of the risks and benefits of long-term osteoporosis treatment:

  • NOT-AR-21-006—Notice of Special Interest: Promoting Research on Mechanisms of Pathogenesis and Pathophysiology of Atypical Femoral Fracture (AFF) and Osteonecrosis of the Jaw (ONJ)
    • This Notice is active through 7/18/2023;
    • standard R01 and R21 due dates apply

Ongoing Opportunities

INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE)

HEAL (Helping to End Addiction Long-term) Related Supplement

  • HEAL NOT-NS-20-107: Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research
  • This notice is part of the NIH’s HEAL Initiative to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative is a trans-NIH effort to (1) improve prevention and treatment strategies for opioid misuse and addiction and (2) enhance pain management. More information about the HEAL Initiative is available at: https://heal.nih.gov/
  • https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-107.html
    • Application Due Date(s) –May 15, 2022, November 15, 2022, February 15, 2023, May 15, 2023, November 15, 2023, February 15, 2024, and May 15, 2024

 

Share